EPIDEMIOLOGY AND TRANSMISSION OF HIV-2 - WHY THERE IS NO HIV-2 PANDEMIC

被引:196
|
作者
DECOCK, KM
ADJORLOLO, G
EKPINI, E
SIBAILLY, T
KOUADIO, J
MARAN, M
BRATTEGAARD, K
VETTER, KM
DOORLY, R
GAYLE, HD
机构
[1] PROJET RETRO CI, ABIDJAN, COTE IVOIRE
[2] EMORY UNIV, SCH PUBL HLTH, ATLANTA, GA 30322 USA
[3] CTR DIS CONTROL & PREVENT, NATL CTR INFECT DIS, DIV HIV AIDS, ATLANTA, GA USA
来源
关键词
D O I
10.1001/jama.270.17.2083
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although human immunodeficiency virus type 1 (HIV-1) and HIV-2 share modes of transmission, their epidemiologic characteristics differ and international spread of HIV-2 has been very limited. Recently, the prevalence of infection with HIV-1 but not HIV-2 has increased rapidly in different West African countries, where HIV-2 was probably present earlier. Among 19 701 women of reproductive age tested in Abidjan, Ivory Coast, between 1988 and 1992, the prevalence of HIV-1 infection increased from 5.0% to 9.2%, while that of HIV-2 declined from 2.6% to 1.5%. Differences in viral load may be responsible: reported results of virus culture and polymerase chain reaction assays suggest that at high CD4+ T-lymphocyte counts viral load is lower in HIV-2-infected than in HIV-1-infected persons; the efficacy of heterosexual and perinatal transmission of HIV-2 is less efficient than that of HIV-1 at this stage. At low (<0.20 x 10(9)/L [<200/muL]) CD4+ T-lymphocyte counts, virus isolation is equally successful for both viruses, and the efficacy of heterosexual transmission is similar. Differences in HIV-1 and HIV-2 natural history are reflected in differences in viral load, that for HIV-2 being lower until immunodeficiency is severe. Differences in viral load throughout most of the natural history of infection appear to correlate with lower transmissibility of HIV-2 than HIV-1, and are the likeliest explanation for their markedly different global epidemiology.
引用
收藏
页码:2083 / 2086
页数:4
相关论文
共 50 条
  • [31] RECOMBINANT PEPTIDES DERIVED FROM THE ENVELOPE OF HIV-2 IN THE SERODIAGNOSIS OF HIV-2 INFECTIONS
    OBERHUBER, W
    SCHULZ, TF
    HOFBAUER, JM
    HENGSTER, P
    LARCHER, C
    WACHTER, H
    DIERICH, MP
    IMMUNOBIOLOGY, 1988, 178 (1-2) : 67 - 67
  • [32] Plasma and tissue HIV-1 and HIV-2 viral load in HIV-2 and dual HIV-1/HIV-2 infected individuals: Implications for starting HAART
    Schutten, M
    van der Ende, ME
    Tenner-Racz, K
    Racz, P
    Niesters, HGM
    Osterhaus, ADME
    AIDS, 2000, 14 : S3 - S3
  • [33] HIV-2 infection and chemokine receptors usage - Clues to reduced virulence of HIV-2
    Azevedo-Pereira, JM
    Santos-Costa, Q
    Moniz-Pereira, J
    CURRENT HIV RESEARCH, 2005, 3 (01) : 3 - 16
  • [34] Update on HIV-2 infection
    Matheron, S.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 : 51 - 51
  • [35] HIV-2 - EFFECT ON SPECIFICITY
    JURGENSEN, P
    EVANS, J
    SKORA, C
    FALCON, RL
    PETERSEN, MB
    DALUGA, C
    DAANEN, B
    WANCHO, A
    GALLARDA, JL
    LIU, D
    TRANSFUSION, 1994, 34 (10) : S44 - S44
  • [36] ROUTES OF HIV-2 TRANSMISSION IN WESTERN-EUROPE
    KROEGEL, C
    HESS, G
    ZUMBUSCHENFELDE, KHM
    LANCET, 1987, 1 (8542): : 1150 - 1150
  • [37] HIV-2 INFECTION IN CZECHOSLOVAKIA
    BRUCKOVA, M
    KOPECKA, D
    SYRUCEK, L
    VOJTECHOVSKY, K
    PETKOV, V
    ACTA VIROLOGICA, 1989, 33 (02) : 191 - 191
  • [38] HIV-2 INFECTION IN DENMARK
    KVINESDAL, BB
    WORM, AM
    LINDHARDT, BO
    JENSEN, BL
    NIELSEN, CM
    POULSEN, AG
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1992, 24 (04) : 419 - 421
  • [39] SEROPOSITIVITY TO HIV-1 AND HIV-2
    HAYES, RJ
    SMITH, PG
    LANCET, 1987, 1 (8543): : 1199 - 1200
  • [40] HIV-2 - OCCURRENCE AND CONSEQUENCES
    BREDE, HD
    ZUMTHEMA, HR
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1987, 129 (19): : 347 - 347